abstract |
The present invention relates to vectors based on the Mononegavirales order, in particular rabies virus. More specifically, the present invention relates to a vector that can be converted between a clone-capable form and a copy-capable form that have been transfected into a target cell. Among other applications, the present invention avoids cytotoxicity associated with current vectors based on rabies virus. |